Aveanna Healthcare (NASDAQ:AVAH) Price Target Lowered to $5.50 at Truist Financial

Aveanna Healthcare (NASDAQ:AVAH - Free Report) had its target price decreased by Truist Financial from $6.00 to $5.50 in a research note released on Friday morning,Benzinga reports. Truist Financial currently has a hold rating on the stock.

Separately, UBS Group lifted their price objective on Aveanna Healthcare from $3.20 to $4.50 and gave the stock a "sell" rating in a research report on Friday, March 14th.

Aveanna Healthcare Stock Performance

AVAH stock remained flat at $4.54 during mid-day trading on Friday. 57,070 shares of the company's stock were exchanged, compared to its average volume of 253,738. The company's fifty day moving average price is $4.78 and its 200 day moving average price is $4.92. Aveanna Healthcare has a 12 month low of $2.11 and a 12 month high of $6.19. The stock has a market cap of $885.73 million, a PE ratio of -13.35 and a beta of 1.99.

Insider Buying and Selling at Aveanna Healthcare

In other news, major shareholder J.H. Whitney Equity Partners V sold 5,580 shares of the company's stock in a transaction on Tuesday, April 1st. The stock was sold at an average price of $5.63, for a total value of $31,415.40. Following the transaction, the insider now owns 1,451,598 shares of the company's stock, valued at $8,172,496.74. This represents a 0.38 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Insiders have sold 67,412 shares of company stock worth $372,142 in the last ninety days. 7.80% of the stock is owned by insiders.

Remove Ads

Institutional Trading of Aveanna Healthcare

Several institutional investors and hedge funds have recently bought and sold shares of the stock. Price T Rowe Associates Inc. MD increased its position in shares of Aveanna Healthcare by 5.2% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 53,699 shares of the company's stock valued at $246,000 after acquiring an additional 2,649 shares during the last quarter. Rhumbline Advisers boosted its position in shares of Aveanna Healthcare by 4.0% during the 1st quarter. Rhumbline Advisers now owns 75,581 shares of the company's stock worth $410,000 after purchasing an additional 2,918 shares during the period. Empirical Financial Services LLC d.b.a. Empirical Wealth Management increased its holdings in Aveanna Healthcare by 15.7% in the 4th quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 25,171 shares of the company's stock valued at $115,000 after purchasing an additional 3,407 shares during the last quarter. Charles Schwab Investment Management Inc. raised its position in Aveanna Healthcare by 0.9% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 466,706 shares of the company's stock valued at $2,133,000 after purchasing an additional 4,047 shares during the period. Finally, SG Americas Securities LLC lifted its stake in Aveanna Healthcare by 26.0% during the fourth quarter. SG Americas Securities LLC now owns 24,366 shares of the company's stock worth $111,000 after purchasing an additional 5,031 shares in the last quarter. 87.96% of the stock is currently owned by hedge funds and other institutional investors.

About Aveanna Healthcare

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.